Jeffrey Lawrence
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
Papers in
-
- Peroxisome Proliferator-Activated Receptors 6
- Cancer therapeutics and mechanisms 3
-
- Liver Disease Diagnosis and Treatment 5
- Co-authors
- W. van Walbeek (2 shared papers)Peter Scott (1 shared paper)Thomas C. Rowe (3 shared papers)Volkmar Weissig (2 shared papers)Peter Scott (2 shared papers)Patrick I. Eacho (3 shared papers)David J. Kroll (1 shared paper)J. Harwig (1 shared paper)
- Journals
- Chemical Research in Toxicology (3 papers)Canadian Journal of Microbiology (2 papers)The Journal of Urology (2 papers)Carcinogenesis (1 paper)Assay and Drug Development Technologies (1 paper)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Jeffrey Lawrence
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Pharmacology 122
- Clinical Biochemistry 66
- Molecular Biology 577
- Cell Biology 120
- Plant Science 266
Countries citing papers authored by Jeffrey Lawrence
This map shows the geographic impact of Jeffrey Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Lawrence more than expected).
Fields of papers citing papers by Jeffrey Lawrence
This network shows the impact of papers produced by Jeffrey Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Lawrence. The network helps show where Jeffrey Lawrence may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeffrey Lawrence, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1970 | 218 | |
| 2 | 2001 | 160 | |
| 3 | 2004 | 101 | |
| 4 | 1996 | 94 | |
| 5 | 1969 | 90 | |
| 6 | 1993 | 74 | |
| 7 | 2000 | 73 | |
| 8 | 2010 | 71 | |
| 9 | 2004 | 39 | |
| 10 | 2001 | 38 | |
| 11 | 2006 | 34 | |
| 12 | 2008 | 31 | |
| 13 | 2001 | 30 | |
| 14 | 2013 | 28 | |
| 15 | 2021 | 16 | |
| 16 | 2001 | 12 | |
| 17 | 1968 | 8 | |
| 18 | 1995 | 6 | |
| 19 | 2018 | 6 | |
| 20 | 1996 | 4 |
About Jeffrey Lawrence
Jeffrey Lawrence is a scholar working on Molecular Biology, Epidemiology, Oncology, Organic Chemistry and Pharmacology, having authored 24 papers that have together received 1.1k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Drug Transport and Resistance Mechanisms (5 papers), Prostate Cancer Treatment and Research (3 papers), Cancer therapeutics and mechanisms (3 papers), Endoplasmic Reticulum Stress and Disease (2 papers), Metabolism and Genetic Disorders (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Pharmacology (122 citations), Clinical Biochemistry (66 citations), Molecular Biology (577 citations), Cell Biology (120 citations) and Plant Science (266 citations). Jeffrey Lawrence has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include W. van Walbeek, Peter Scott, Thomas C. Rowe, Volkmar Weissig, Peter Scott, Patrick I. Eacho, David J. Kroll, J. Harwig, John G. DeLuca and Diane R. Umbenhauer. Their work appears in journals such as Chemical Research in Toxicology, Canadian Journal of Microbiology, The Journal of Urology, Carcinogenesis and Assay and Drug Development Technologies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.